The Most Expensive Medical Conditions In America
Health AffairsPublished 1 July 2002
Benjamin G. Druss, Steven C. Marcus, Mark Olfson, Harold Alan Pincus
Citations237
SJR quartileQ1
SJR score4.46
SNIP3.04
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
There was not a significant association between rank order of treatment costs and disability; the conditions with the greatest disability relative to expenditures were mood disorders, chronic obstructive pulmonary disease, and arthropathies.
Abstract
This study uses a nationally representative survey to identify the most expensive conditions in the United States and to examine the association between spending and disability. The most expensive conditions at a population level were ischemic heart disease and motor vehicle accidents; at the per capita level they were respiratory malignancies. There was not a significant association between rank order of treatment costs and disability; the conditions with the greatest disability relative to expenditures were mood disorders, chronic obstructive pulmonary disease, and arthropathies. We use the findings to discuss the role for cost-of-illness and burden-of-disease estimates in setting priorities.
Keywords
Economics, Econometrics and FinanceHealth Professions
JAMAThe Medical Outcomes Study. An application of methods for monitoring the results of medical care
1,229 Citations1989Alvin R. Tarlov
The Medical Outcomes Study was designed to determine whether variations in patient outcomes are explained by differences in system of care, clinician specialty, and clinicians' technical and interpersonal styles and develop more practical tools for the routine monitoring of patient outcomes in medical practice.
JAMABurden of Disease—Implications for Future Research
598 Citations2001Catherine M. Michaud
The challenge for research in the 21st century is to maintain and improve life expectancy and the quality of life that was achieved for most of the world's population during the 20th century.
JAMASetting Health Care Priorities in Oregon
441 Citations1991David C. Hadorn
Oregon's final priority list was generated without reference to costs and is, therefore, more intuitively sensible than the initial list, but the utility of the final list is limited by its lack of specificity with regard to conditions and treatments.
Health AffairsThe Concentration Of Health Care Expenditures, Revisited
372 Citations2001Marc L. Berk, Alan C. Monheit
The findings show that the skewed concentration of health care expenditures has remained very stable; 5 percent of the population accounts for the majority of health expenditures.
PubMedThe Medical Expenditure Panel Survey: a national health information resource.
341 Citations1997J Cohen, Alan C. Monheit +7 more
Each of the MEPS components is discussed, focusing on design enhancements that have been made since the survey was last conducted nearly a decade ago, to examine how individual and family characteristics, including the characteristics of their health insurance, affect medical care use and spending.
American Journal of PsychiatryCost-Effectiveness of a Collaborative Care Program for Primary Care Patients With Persistent Depression
330 Citations2001Gregory E. Simon, Wayne Katon +7 more
A stepped collaborative care program for depressed primary care patients led to substantial increases in treatment effectiveness and moderate increases in costs, consistent with those of other randomized trials.
PubMedDeaths: preliminary data for 2000.
181 Citations2001Arialdi Miniño, Betty Smith
The age-adjusted death rate in 2000 for the United States decreased slightly from 1999 to a record low in 2000, and declines in age- adjusted rates occurred for heart disease, stroke, Chronic liver disease and cirrhosis, diabetes, and cancer.
Health PolicyCost of illness studies: An aid to decision-making?
176 Citations1987Alan Shiell, Karen Gerard +1 more
The theoretical errors of the approach are restated, its limitations for policy are indicated and economics can offer something more useful than a method for estimating the ‘benefits of the unattainable’.
Journal of Health EconomicsTheories of justice and their implications for priority setting in health care
141 Citations1997Jan Abel Olsen
It is shown how three theories of distributive justice; utilitarianism, egalitarianism and maximum, can provide a clearer understanding of the normative basis of different priority setting regimes in the health service.
BioethicsRATIONING FAIRLY: PROGRAMMATIC CONSIDERATIONS
131 Citations1993Norman Daniels
It is suggested that exploring a theory of rationing in this way is a prolegomenon to serious work in "applied ethics" and against provincialism.
PharmacoEconomicsUsefulness of US Cost-of-Illness Studies in Healthcare Decision Making
124 Citations2001Bernard S. Bloom, Douglas J. Bruno +2 more
The wide variation of cost estimates for the same diagnosis raises serious questions of comparability, accuracy, validity and usefulness of all studies.
Health PolicySOUNDING BOARD
49 Citations1998Virginia Wiseman, Gavin Mooney
It is argued that in terms of priorities for health services, BOI calculations are irrelevant except possibly in the context of some (less than ideal) concept of need in support of equity and it is better to concentrate in priority setting on estimating the costs and benefits of marginal changes than devoting scarce analytical resources to superfluous estimates of BOI.